S&S Healthcare Holding (ROCO:4198) Shares Outstanding (EOP): 24.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4198 S&S Healthcare Holding Ltd ROCO:4198
54 GF Score
Price NT$38.05
GF Value NT$23.68
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is S&S Healthcare Holding Shares Outstanding (EOP)?

S&S Healthcare Holding ROCO:4198 -5.11% 54 Shares Outstanding (EOP) is 24.1 Mil as of Dec. 2025. GuruFocus rates ROCO:4198 with a GF Score™ of 54/100 and a GF Value™ of NT$23.68 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. S&S Healthcare Holding's shares outstanding for the quarter that ended in Dec. 2025 was 24.1 Mil.

S&S Healthcare Holding's quarterly shares outstanding stayed the same from Sep. 2025 (24.1 Mil) to Dec. 2025 (24.1 Mil).

S&S Healthcare Holding's annual shares outstanding stayed the same from Dec. 2024 (24.1 Mil) to Dec. 2025 (24.1 Mil).


S&S Healthcare Holding  (ROCO:4198) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


S&S Healthcare Holding Shares Outstanding (EOP) Related Terms


S&S Healthcare Holding Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for S&S Healthcare Holding's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

S&S Healthcare Holding Shares Outstanding (EOP) Chart

S&S Healthcare Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.11 22.11 24.11 24.11 24.11

S&S Healthcare Holding Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.11 24.11 24.11 24.11 24.11

ROCO:4198 vs ABT, SYK, MDT: Shares Outstanding (EOP) Comparison

For the Medical Devices subindustry, S&S Healthcare Holding's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


S&S Healthcare Holding Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, S&S Healthcare Holding's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where S&S Healthcare Holding's Shares Outstanding (EOP) falls into.


ROCO:4198
54GF Score
S&S Healthcare Holding Ltd ROCO:4198
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

S&S Healthcare Holding Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 24.1 Mil mean?
S&S Healthcare Holding (ROCO:4198) has a Shares Outstanding (EOP) of 24.1 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on S&S Healthcare Holding and its competitors.
Is S&S Healthcare Holding's Shares Outstanding (EOP) too high?
S&S Healthcare Holding's current Shares Outstanding (EOP) is 24.1 Mil. Overall, S&S Healthcare Holding has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does S&S Healthcare Holding's Shares Outstanding (EOP) compare to ABT and SYK?
S&S Healthcare Holding's Shares Outstanding (EOP) of 24.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on S&S Healthcare Holding and its competitors. S&S Healthcare Holding's current Shares Outstanding (EOP) is 24.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S&S Healthcare Holding stock overvalued right now?
Based on GuruFocus' analysis, S&S Healthcare Holding (ROCO:4198) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$23.68, compared to a current price of NT$38.05 — trading 60.7% above its estimated fair value. The current Shares Outstanding (EOP) is 24.1 Mil. S&S Healthcare Holding's overall GF Score™ is 54/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For S&S Healthcare Holding (ROCO:4198), the current Shares Outstanding (EOP) is 24.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is S&S Healthcare Holding (ROCO:4198) Overvalued in 2026?

Based on GuruFocus' analysis, S&S Healthcare Holding stock appears to be overvalued. The current stock price of NT$38.05 is trading 60.7% above its estimated GF Value™ of NT$23.68. GuruFocus considers S&S Healthcare Holding to be Significantly Overvalued.

Key valuation signals for ROCO:4198:

  • Shares Outstanding (EOP): 24.1 Mil
  • GF Value™: NT$23.68 vs. price of NT$38.05 (60.7% above fair value)
  • GF Score™: 54/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


S&S Healthcare Holding Business Description

Address 7th Floor, Number 89, Xinhu 1st Road, Taipei, TWN, 114
S&S Healthcare Holding Ltd, formerly Swissray Global Healthcare Holding Ltd is involved in providing DR systems designed for any application in general radiography. The product divisions of the company cover Swissray DDR systems, Novadaq, and EZ2GO. The main business projects of the company and its subsidiaries are the research and development, manufacturing, sales, and maintenance services of high-end medical equipment and the manufacturing and sales of basic medical equipment.
54GF Score

Get the complete analysis for ROCO:4198

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.05
Price
NT$23.68
GF Value